Products for Out-Licensing

Products Out-Licensing

NAL develops novel dosage forms and proprietary drug delivery systems based on Company’s captive Drug Delivery System (“DDS”) technologies. NAL expects to partner with pharmaceutical companies for the development and commercialization of the NAL products in global markets.

The partial listing of NAL’s products is outlined below. As we have not disclosed the complete list of our proprietary DDS products under development, please write to us at to know more about NAL’s products and partnering opportunities.

Smoking Cessation
Products Marketed or Under Development (Partial Listing)
Proposed US Filing
NAL2762 Nicotine ODF
505(b)(2) NDA
NAL2766 Nicotine Mini-Lozenge
NAL2771 Nicotine 24-Hour Patch